HOUSTON, TEXAS / ACCESS Newswire / November 25, 2025 / Mann Eye Institute is kicking off the season in style…
SARASOTA, Fla., Nov. 25, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (“INVO”) (NASDAQ: IVF), a healthcare company focused on the…
Combined platform strengthens national footprint, enhances multi-vendor service expertise, and accelerates customer-first innovationOMAHA, Neb., Nov. 25, 2025 (GLOBE NEWSWIRE) --…
CHICAGO, Nov. 25, 2025 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) brought together more than 40 leading clinicians…
Live webcast fireside chat on Thursday, December 4th at 10:30 AM ET Carlsbad, CA, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Palisade…
SAN JOSE, CALIFORNIA / ACCESS Newswire / November 25, 2025 / VSee Health, Inc. (NASDAQ:VSEE), a leader in innovative telemedicine…
Company to advance care through broader access to breadth of skin substitutes across four unique technology platforms Tissue Technologies Integra…
PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA levels in a dose-related…
Three units for demonstration within Verizon Innovation Labs VANCOUVER, BC / ACCESS Newswire / November 25, 2025 / UniDoc Health…
THE WOODLANDS, Texas, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will…